Detalles de la búsqueda
1.
Regulation of androgen receptor activity by tyrosine phosphorylation.
Cancer Cell
; 10(4): 309-19, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17045208
2.
Murine toxicology and pharmacokinetics of novel retinoic acid metabolism blocking agents.
Cancer Chemother Pharmacol
; 60(6): 899-905, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17345084
3.
Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
J Med Chem
; 48(8): 2972-84, 2005 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-15828836
4.
Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy.
J Med Chem
; 46(12): 2345-51, 2003 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-12773039
5.
Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice.
J Med Chem
; 47(27): 6716-29, 2004 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-15615521
6.
Potent CYP17 inhibitors: improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model.
J Steroid Biochem Mol Biol
; 92(3): 155-65, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15555909
Resultados
1 -
6
de 6
1
Próxima >
>>